Merck (MRK) EBIT (2009 - 2026)
Merck's EBIT came in at -$584 million for Q2 2026, compared with $4.99 billion a year earlier.
Powered by 
Analysis
Merck (MRK) EBIT (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Merck reported EBIT of $6.38 billion, down 66.6% year-over-year; for FY2025, it was $21.22 billion, up 6.6% from FY2024.
- EBIT carries a five-year compound annual growth rate of 33.7% (FY2020 to FY2025).
- Going back by year, EBIT was $19.91 billion in FY2024 (-27.3%), $27.39 billion in FY2023 (+52.6%), $17.95 billion in FY2022 (+43.1%) and $12.54 billion in FY2021 (+152.1%).
- The five-year range for quarterly EBIT is -$5.16 billion (Q2 2023) to $6.51 billion (Q3 2025).
- Year-over-year, EBIT increased in three of the last six quarters, with growth averaging 18.2%.
- The fastest year-over-year change in EBIT over five years came in Q2 2022 (growth of 205.1%), and the weakest in Q4 2023 (a decline of 37.2%).
- Business Quant data shows MRK's EBIT at -$3.4 billion (Q1 2026), $3.85 billion (Q4 2025) and $6.51 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 1.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -584.00 Mn |
| Mar 31, 2026 | -3.40 Bn |
| Dec 31, 2025 | 3.85 Bn |
| Sep 30, 2025 | 6.51 Bn |
| Jun 30, 2025 | 4.99 Bn |
| Mar 31, 2025 | 5.87 Bn |
| Dec 31, 2024 | 4.30 Bn |
| Sep 30, 2024 | 3.93 Bn |
| Jun 30, 2024 | 6.05 Bn |
| Mar 31, 2024 | 5.64 Bn |
| Dec 31, 2023 | 2.16 Bn |
| Sep 30, 2023 | 5.75 Bn |
| Jun 30, 2023 | -5.16 Bn |
| Mar 31, 2023 | 3.74 Bn |
| Dec 31, 2022 | 3.44 Bn |
| Sep 30, 2022 | 4.01 Bn |
| Jun 30, 2022 | 4.93 Bn |
| Mar 31, 2022 | 5.57 Bn |
| Dec 31, 2021 | 3.58 Bn |
| Sep 30, 2021 | 4.82 Bn |
API Access
Merck EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();